Journal of Cardiovascular Translational Research, 2022 Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome Christersson C., Baron T., Flachskampf F. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
iScience, 2022 Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19 Buyukozkan M., Alvarez-Mulett S., Racanelli A. et al. Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationSerum | | | | |
International Journal of Cardiology, 2022 Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study) de Lange I., Petersen T., de Bakker M. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Brain Communications, 2022 Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment Kivisäkk P., Magdamo C., Trombetta B. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
Molecular Psychiatry, 2022 Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study Sandberg J., Hansson C., Göteson A. et al. Olink Target 96NeurologyPatient StratificationPlasma | | | | |
Nature Communications, 2022 Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis Damsky W., Wang A., Kim D. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Communications Biology, 2022 Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort Yang J., Jia Z., Song X. et al. Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma | | | | |
BMC Women's Health, 2022 Applicability of polygenic risk scores in endometriosis clinical presentation Svensson A., Garcia-Etxebarria K., Åkesson A. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum | | | | |
Kidney Medicine, 2022 Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay Schmidt I., Colona M., Srivastava A. et al. Olink Target 96Immunological & Inflammatory DiseasesTechnical EvaluationPlasma | | | | |
Journal of the American College of Cardiology, 2022 Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data Tayal U., Verdonschot J., Hazebroek M. et al. Olink Target 96CVDPatient StratificationSerum | | | | |
Annals of Oncology, 2022 Impact of acetaminophen on the efficacy of immunotherapy in cancer patients Bessede A., Marabelle A., Guégan J. et al. OncologyImmunotherapyPatient Stratification | | | | |
Multiple Sclerosis and Related Disorders, 2022 Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL Gawde S., Agasing A., Bhatt N. et al. Olink Target 96NeurologyPatient StratificationSerum | | | | |
Atherosclerosis, 2022 Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach Shafi B., Bøttcher M., Ejupi A. et al. Olink Target 96CVDPathophysiology | | | | |
Osteoporosis International, 2022 Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial Sköld C., Kultima K., Freyhult E. et al. Olink Target 96Other Diseases & SyndromesPathophysiologySerum | | | | |
eBioMedicine, 2022 The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study Jones D., Wetten A., Barron-Millar B. et al. Olink Target 96HepatologyPatient StratificationSerum | | | | |
European Journal of Heart Failure, 2022 Distinct pathophysiological pathways in women and men with heart failure Ravera A., Santema B., de Boer R. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Clinical Kidney Journal, 2022 Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes Laursen J., Søndergaard-Heinrich N., Haddock B. et al. Olink Target 96Metabolic DiseasesNephrologyPathophysiologyPlasma | | | | |
Scientific Reports, 2022 Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction Girerd N., Cleland J., Anker S. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Scientific Reports, 2022 Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome Niroomand A., Ghaidan H., Hallgren O. et al. Olink Target 96Respiratory DiseasesPatient StratificationPlasma | | | | |
Journal of Nephrology, 2022 Assay-related differences in SuPAR levels: implications for measurement and data interpretation Vasbinder A., Raffield L., Gao Y. et al. Olink Target 96NephrologyTechnical EvaluationPlasma | | | | |